Cancer
-
March 15, 2022
Improving care for gynecologic cancer
To reduce risk of deep vein thrombosis in patients being treated for gynecologic cancer, Vanderbilt researchers recommend that providers use Khorana scores and provide prophylactic treatment according to clinical guidelines. -
March 10, 2022
Bots boost liver cancer outcome
Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients. -
March 9, 2022
Martin shares colorectal cancer story, urges early detection
Vanderbilt Wilson County Hospital's Lori Martin uses her own experiences to educate patients about the importance of early detection of colorectal cancer. -
March 7, 2022
Study finds World Trade Center responders at higher risk for blood cancer-associated mutations
A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease -
February 24, 2022
Melanoma treatment response
Targeting the interaction between melanoma and immune cells could improve responses to targeted cancer therapies, Vanderbilt researchers found. -
February 17, 2022
Park named director of Vanderbilt-Ingram Cancer Center
Ben Ho Park, MD, PhD, deputy director of the Vanderbilt-Ingram Cancer Center, has been named the center’s new director. -
February 17, 2022
Grant to support Haake’s research on kidney cancer
Kure It Cancer Research has awarded a $200,000 grant to support kidney cancer research by Vanderbilt's Scott Haake, MD.